Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Congress Must Update FDA Regulations for Medical AI
17
Zitationen
1
Autoren
2024
Jahr
Abstract
This JAMA Forum discusses pending legislation in the US House and Senate and the history of the “firm-based approach” the US Food and Drug Administration (FDA) could use when regulating artificial intelligence (AI) medical devices to augment patient care.
Ähnliche Arbeiten
Explainable Artificial Intelligence (XAI): Concepts, taxonomies, opportunities and challenges toward responsible AI
2019 · 8.469 Zit.
Stop explaining black box machine learning models for high stakes decisions and use interpretable models instead
2019 · 8.358 Zit.
High-performance medicine: the convergence of human and artificial intelligence
2018 · 7.803 Zit.
Proceedings of the 19th International Joint Conference on Artificial Intelligence
2005 · 5.781 Zit.
Peeking Inside the Black-Box: A Survey on Explainable Artificial Intelligence (XAI)
2018 · 5.542 Zit.